In Brief: Servier, IDEAYA Partner On Darovasertib For Uveal Melanoma

 
• By Mary Jo Laffler
  
Eye
Darovasertib is in late-stage development for the rare eye cancer uveal melanoma • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business